Financhill
Sell
27

KLTO Quote, Financials, Valuation and Earnings

Last price:
$0.38
Seasonality move :
2.55%
Day range:
$0.40 - $0.44
52-week range:
$0.11 - $3.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.93x
Volume:
949.7K
Avg. volume:
742.6K
1-year change:
-9.25%
Market cap:
$29M
Revenue:
--
EPS (TTM):
-$0.33

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Klotho Neurosciences, Inc. has -- downside to fair value with a price target of -- per share.

KLTO vs. S&P 500

  • Over the past 5 trading days, Klotho Neurosciences, Inc. has underperformed the S&P 500 by -19.58% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Klotho Neurosciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Klotho Neurosciences, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Klotho Neurosciences, Inc. reported revenues of --.

Earnings Growth

  • Klotho Neurosciences, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Klotho Neurosciences, Inc. reported earnings per share of -$0.05.
Enterprise value:
21.7M
EV / Invested capital:
2.19x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
-3.93x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-195.82%
Net Income Margin (TTM):
--
Return On Equity:
-236.57%
Return On Invested Capital:
-216.68%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$933.3K -$4M -$7.2M -$2.9M -$1.9M
EBITDA -$933.3K -$4M -$7.2M -$2.9M -$1.9M
Diluted EPS $0.10 -$0.26 -$0.33 -$0.18 -$0.05
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets -- $555.1K $203.8K $154.6K $7.8M
Total Assets -- $117.2M $58M $2.5M $10.1M
Current Liabilities -- $218.4K $1.7M $982.4K $92.9K
Total Liabilities -- $4.6M $7.2M $1M $145.9K
Total Equity -- $112.6M $50.8M $1.5M $9.9M
Total Debt -- -- $1.1M -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$365.6K -$1.9M -$5.5M -$1.1M -$1.1M
Cash From Investing -$76.3K -$76.8K -- -- --
Cash From Financing $295K $2.2M $12.8M $278.5K $5.3K
Free Cash Flow -$442K -$2.1M -$5.5M -$1.1M -$1.1M
KLTO
Sector
Market Cap
$29M
$29M
Price % of 52-Week High
10.24%
52.89%
Dividend Yield
0%
0%
Shareholder Yield
-34.42%
-1.4%
1-Year Price Total Return
-9.25%
-19%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $0.45
200-day SMA
Sell
Level $0.59
Bollinger Bands (100)
Sell
Level 0.42 - 0.8
Chaikin Money Flow
Buy
Level 365.4M
20-day SMA
Sell
Level $0.46
Relative Strength Index (RSI14)
Sell
Level 38.46
ADX Line
Sell
Level 14.12
Williams %R
Buy
Level -99.6667
50-day SMA
Sell
Level $0.51
MACD (12, 26)
Sell
Level -0.02
25-day Aroon Oscillator
Sell
Level -36
On Balance Volume
Neutral
Level 2.5B

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-7.7943)
Sell
CA Score (Annual)
Level (-11.7686)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (19.1037)
--
Piotroski F Score (Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (1)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Omaha, NE.

Stock Forecast FAQ

In the current month, KLTO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KLTO average analyst price target in the past 3 months is --.

  • Where Will Klotho Neurosciences, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Klotho Neurosciences, Inc. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Klotho Neurosciences, Inc.?

    Analysts are divided on their view about Klotho Neurosciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Klotho Neurosciences, Inc. is a Sell and believe this share price will rise from its current level to --.

  • What Is Klotho Neurosciences, Inc.'s Price Target?

    The price target for Klotho Neurosciences, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is KLTO A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Klotho Neurosciences, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of KLTO?

    You can purchase shares of Klotho Neurosciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Klotho Neurosciences, Inc. shares.

  • What Is The Klotho Neurosciences, Inc. Share Price Today?

    Klotho Neurosciences, Inc. was last trading at $0.38 per share. This represents the most recent stock quote for Klotho Neurosciences, Inc.. Yesterday, Klotho Neurosciences, Inc. closed at $0.40 per share.

  • How To Buy Klotho Neurosciences, Inc. Stock Online?

    In order to purchase Klotho Neurosciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Are the Best AI Power Stocks?
What Are the Best AI Power Stocks?

As the construction of AI infrastructure accelerates, the gap between…

Is IONQ The Best Quantum Stock to Buy?
Is IONQ The Best Quantum Stock to Buy?

Riding a wave of investor enthusiasm for the technology, quantum…

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 60x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
73
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 39x

Alerts

Buy
80
FEIM alert for Dec 15

Frequency Electronics, Inc. [FEIM] is down 8.5% over the past day.

Buy
57
MOD alert for Dec 15

Modine Manufacturing Co. [MOD] is up 1.6% over the past day.

Sell
42
OKLO alert for Dec 15

Oklo, Inc. [OKLO] is down 2.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock